CORTERIA PHARMACEUTICALS
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
CORTERIA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.corteriapharma.com
Status:
Active
Total Funding:
12 M EUR
Technology used in webpage:
Microsoft Exchange Online
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Philip Janiak Founder & CEO @ Corteria Pharmaceuticals
Founder & CEO
Marie-Laure Ozoux Founder & Chief Scientific Officer @ Corteria Pharmaceuticals
Founder & Chief Scientific Officer
Regis Olivier CFO @ Corteria Pharmaceuticals
CFO
Founder
Investors List
Omnes Capital
Omnes Capital investment in Seed Round - Corteria Pharmaceuticals
V-Bio Ventures
V-Bio Ventures investment in Seed Round - Corteria Pharmaceuticals
Invivo Capital Partners
Invivo Capital Partners investment in Seed Round - Corteria Pharmaceuticals
Kurma Partners
Kurma Partners investment in Seed Round - Corteria Pharmaceuticals
Official Site Inspections
http://www.corteriapharma.com
- Host name: cluster027.hosting.ovh.net
- IP address: 54.36.91.62
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Corteria Pharmaceuticals"
Home page - Corteria
About us FOCUSED ON THE DEVELOPMENT OF TRANSFORMATIVE THERAPIES FOR …See details»
Leadership - Corteria
Regis brings more than 30 years of experience in the areas of finance, structuring and …See details»
Board of directors - Corteria - corteriapharma.com
Andreas was part of several successful product developments and market introductions. Before the integration of Genentech (now a wholly owned member of The Roche Group), Andreas was Global Head of Clinical Research and …See details»
Corteria Pharmaceuticals - Crunchbase Company Profile & Funding
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused …See details»
Corteria Pharmaceuticals - VentureRadar
"Founded in 2021, Corteria Pharmaceuticals is a privately held company developing first-in …See details»
Corteria Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
View Corteria Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Corteria Pharmaceuticals - EU-Startups
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.See details»
Corteria Pharmaceuticals - LinkedIn
Corteria Pharmaceuticals | 1,836 followers on LinkedIn. Interceptive therapies for the treatment of heart failure subpopulations | Development of transformative therapies for the treatment of ...See details»
Corteria Pharmaceuticals Announces a €65M ($71M) Financing to …
Paris (France), 07 September 2023 – Corteria Pharmaceuticals (“Corteria”), a …See details»
Corteria Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
More information available at: www.corteriapharma.com [1] Applying a 1.0886 EUR/USD …See details»
Corteria Pharmaceuticals Company Profile: Overview and Full …
Corteriapharma.com Overview: Corteria Pharmaceuticals Corteria Pharmaceuticals, located in …See details»
Corteria Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
View Corteria Pharmaceuticals (corteriapharma.com) location in Ile-de-France, France , revenue, industry and description. Find related and similar companies as well as employees by title and much more. Products. Contact & Company Search …See details»
Corteria Pharmaceuticals strengthens its Executive Leadership …
Oct 21, 2022 Corteria Pharmaceuticals, a biotechnology company developing innovative …See details»
V-Bio Ventures portfolio company Corteria Pharmaceuticals raises …
Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio …See details»
Corteria Pharmaceuticals Announces a 65M ($71M Financing to …
More information available at: www.corteriapharma.com Investors/media contacts Stéphane …See details»
Corteria Pharmaceuticals Company Information - Funding, …
Https://corteriapharma.com. Interceptive therapies for heart failure subpopulations. GET THE …See details»
Corteria Pharmaceuticals Announces Closing of €12M Seed …
Www.corteriapharma.com PRESS RELEASE Corteria Pharmaceuticals Announces Closing of …See details»
Corteria Pharmaceuticals lève 65 millions d’euros pour poursuivre …
Paris, France, le 7 septembre 2023 – Corteria Pharmaceuticals (‘Corteria’), société …See details»
Corteria Pharmaceuticals Announces a €65M Financing to Advance ...
Paris (France), 07 September 2023 – Corteria Pharmaceuticals (“Corteria”), a …See details»
Corteria Pharmaceuticals Announces Closing of €12M Seed …
Paris, France, December 09th, 2021 – Corteria Pharmaceuticals, a French biotechnology …See details»